AQP7P5

Across TCGA pan-cancer cohorts, AQP7P5 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated AQP7P5 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher AQP7P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AQP7P5 expression acts as an unfavorable survival marker.

KIRC, LIHC, and KIRP are the cancer types where AQP7P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.038	0.632	<.001	48	view →
LIHC	DFS	Tertile	All	0.114	0.546	<.001	42	view →
KIRP	OS	Tertile	II,III,IV	0.188	0.771	.016	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
PAAD	OS	Tertile	All	0.214	0.476	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

AQP7P5–KIRC (DFS)

Open the KIRC breakdown →